What Are the Fundamentals of Anheuser-Busch Inbev SA Sponsored (BUD)?

More and more people are talking about Anheuser-Busch Inbev SA Sponsored over the last few weeks. Is it worth buying the Beverages stock at a price of $64.25? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Anheuser-Busch Inbev SA Sponsored has moved 11.1% over the last year, and the S&P 500 logged a change of -7.6%

  • BUD has an average analyst rating of hold and is -3.64% away from its mean target price of $66.68 per share

  • Its trailing earnings per share (EPS) is $2.91

  • Anheuser-Busch Inbev SA Sponsored has a trailing 12 month Price to Earnings (P/E) ratio of 22.1 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $3.8 and its forward P/E ratio is 16.9

  • The company has a Price to Book (P/B) ratio of 10.4 in contrast to the S&P 500's average ratio of 2.95

  • Anheuser-Busch Inbev SA Sponsored is part of the Consumer Staples sector, which has an average P/E ratio of 24.36 and an average P/B of 4.29

  • BUD has reported YOY quarterly earnings growth of 44.8% and gross profit margins of 0.5%

  • The company has a free cash flow of $5,633,500,160.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Anheuser-Busch InBev SA/NV produces, distributes, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.